Take charge of your well-being and reach out to us without hesitation
People commonly experience some or all of the following side effects after stopping GLP-1 medications, says Goddard: Increased hunger (often noticeably stronger) Food noise, often described as the persistent mental chatter about eating and cravings Weight regain, which research shows can begin within weeks Changes in blood sugar control, particularly for people with type 2 diabetes Loss of some cardiometabolic benefits gained during treatment Improvement in GLP-1-related side effects such as nausea, constipation and bloating Not everyone experiences every one of these changes, and their severity varies widely
TB-500, a synthetic fragment of Thymosin Beta-4, regulates actin polymerization and F-actin formation
For millions of people, that date could become a game changer.
Mounjaro 5mg Vial (tirzepatide) is an innovative injectable therapy developed by Eli Lilly and Company, designed to support blood glucose regulation and weight management in adults under medical supervision